title: [Innovations in cardiology. We are too fast with new methods].
abstract: Cardiology is rapidly developing on many levels. New treatment methods are introduced at ever decreasing intervals. Against the background of economization of other areas in medicine, dangers are lurking here for patients if safety, usefulness and sustainability of the treatment methods cannot be sufficiently proven. The German Federal Ministry of Health (Bundesministerium für Gesundheit, BMG) aims to adjust the regulatory framework for the approval of new medical products to the legal requirements of the European Union. With the establishment of the Institute for Quality Assessment and Transparency in Health Care (Institut für Qualitätssicherung und Transparenz im Gesundheitswesen, IQTIG) more precise quality controls should be carried out. Implantation registers will be soon implemented and the routinely performed quality control of different interventions will be coordinated across different healthcare sectors in order to achieve a better understanding of long-term results. Medicine in general and the safety of patients in particular, ultimately benefit from more stringent controls, neutrality and transparency in the assessment of new methods.
authors.affiliation: Herz- und Gefäßklinik Bad Neustadt, Salzburger Leite 1, 97616, Bad Neustadt an der Saale, Deutschland. Anno.Diegeler@herzchirurgie.de.
authors.forename: A
authors.initials: A
authors.lastname: Diegeler
mesh_terms: D002309:Cardiology / Q000295:instrumentation* / Q000639:trends; D018795:Device Approval / Q000331:legislation & jurisprudence* / Q000592:standards; D004059:Diffusion of Innovation; D004867:Equipment Design; D004868:Equipment Failure; D004864:Equipment and Supplies / Q000592:standards*; D005858:Germany; D006801:Humans; D019300:Medical Errors / Q000517:prevention & control*; D061214:Patient Safety / Q000331:legislation & jurisprudence / Q000592:standards
keywords: Cardiology; Innovation; Medical Devices Act; New technologies; Quality assessment